Prof. Dr. Nicolai Burzlaff



Organisation


Professur für Anorganische Chemie


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 4 Go to next page Go to last page

Schley, G., Klanke, B., Kalucka, J., Schatz, V., Daniel, C., Mayer, M.,... Willam, C. (2019). Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis. Kidney International. https://dx.doi.org/10.1016/j.kint.2019.02.016
Fritsch, N., Wick, C., Waidmann, T., Pflock, S., Dral, P., Tucher, J.,... Burzlaff, N. (2018). 1D Chains of Diruthenium Tetracarbonyl Sawhorse Complexes. European Journal of Inorganic Chemistry, 1, 54-61. https://dx.doi.org/10.1002/ejic.201701246
Mayer, M., Fey, K., Heinze, E., Wick, C., Abboud, M.I., Yeh, T.L.,... Burzlaff, N. (2018). A Fluorescent Benzo[g]isoquinoline-based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging. Chemmedchem. https://dx.doi.org/10.1002/cmdc.201800483
Beyer, A., von Gernler, M., Pflock, S., Türkoglu, G., Müller, L., Zahl, A.,... Burzlaff, N. (2018). Alkali-Metal-Templated Self-Assembly of Nickel(II) [12-MC-3] Metallacoronates Based on Bis(pyrazol-1-yl)acetato Ligands. Chemistry - A European Journal, 2018(6), 765-777. https://dx.doi.org/10.1002/ejic.201701400
Schellinger, I.N., Cordasic, N., Panesar, J., Buchholz, B., Jacobi, J., Hartner, A.,... Hilgers, K.F. (2017). Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease. Kidney International, 91(3), 616-627. https://dx.doi.org/10.1016/j.kint.2016.09.028
Spörler, S., Strinitz, F., Rodehutskors, P.M., Müller, L., Waterloo, A., Dürr, M.,... Burzlaff, N. (2016). Carbon-rich cyclopentadienyl ruthenium allenylidene complexes. New Journal of Chemistry, 40(7), 6127-6134. https://dx.doi.org/10.1039/c5nj03556b
Mulay, S.R., Eberhard, J.N., Desai, J., Marschner, J.A., Kumar, S.V., Weidenbusch, M.,... Anders, H.J. (2016). Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease. Journal of the American Society of Nephrology. https://dx.doi.org/10.1681/ASN.2016040486
Heim, C., Bernhardt, W., Jalilova, S., Wang, Z., Motsch, B., Ramsperger-Gleixner, M.,... Ensminger, S.M. (2016). Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model. Interactive Cardiovascular and Thoracic Surgery, 22(5), 561-70. https://dx.doi.org/10.1093/icvts/ivv352
Heim, C., Motsch, B., Jalilova, S., Bernhardt, W.M., Ramsperger-Gleixner, M., Burzlaff, N.,... Ensminger, S. (2016). Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse model. Transplant Immunology, 39, 66-73. https://dx.doi.org/10.1016/j.trim.2016.08.007
Schley, G., Scholz, H., Kraus, A., Hackenbeck, T., Klanke, B., Willam, C.,... Buchholz, B. (2015). Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to enhance tubulogenesis. Kidney International, 88(6), 1283-1292. https://dx.doi.org/10.1038/ki.2015.214

Last updated on 2016-05-05 at 05:12